Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2001

View Archived Issues

SBIR grant awarded to Antigen Express for development of prostate cancer cell vaccine

Alizyme makes significant progress across product development portfolio during 2000

Adolor advances lead product into phase III trials during 2000

Study demonstrates Origenix compounds effective against HBV replication

OBJECT trial results reported to favor Ditropan XL over Detrol

Cubist achieves milestone for Cidecin, triggering payment from Gilead

ConjuChem's CJC-1008 demonstrates positive phase I results

Oral formulation of Isis antisense drug enters clinical evaluation

Abbott presents new antimitotic sulfonates and prodrugs with improved PK profile at ACS meeting

Noninvasive lung cancer diagnostic launched in E.U.

Cyclotriphosphazene-platinum(II) conjugate selected by Korean researchers as clinical candidate

Natrecor scheduled for FDA advisory committee review

SPC-8490, a third-generation SERM active against gynecological tumors, devoid of uterine stimulation

Orion's Simdax receives favorable opinion in several E.U. countries

Panacos and the NCI begin joint HIV drug discovery program

Nonbenzamidine factor Xa inhibitors from DuPont with excellent in vitro profile and improved PK

Pyridine-based inhibitors of cell cycle kinases in the AstraZeneca pipeline

Chemokine receptor modulators and their use in therapy reported by AstraZeneca

Novel series of broad-spectrum antibacterial agents claimed in recent patent

U.S. patent covers altered peptide ligands, including NBI-6024, and use in diabetes Rx

Schering AG presents new NOS inhibitors

Naturally produced antibiotics especially active against mycobacteria, according to MCRF

Quinoline derivatives synthesized at Nippon Soda are potent and selective PDE5 inhibitors

Aminothiazole CDK2 inhibitors undergo preclinical testing at BMS

Phytopharm's P-57 well tolerated in first stage of proof-of-principle trial

First patient treated in phase I study of Alzheimer's disease gene therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...